Home/Filings/4/0001209191-22-047170
4//SEC Filing

Lin Celia 4

Accession 0001209191-22-047170

CIK 0001831828other

Filed

Aug 22, 8:00 PM ET

Accepted

Aug 23, 4:11 PM ET

Size

8.2 KB

Accession

0001209191-22-047170

Insider Transaction Report

Form 4
Period: 2022-08-19
Lin Celia
Chief Medical Officer
Transactions
  • Award

    Class A Common Stock

    2022-08-19+12,50012,500 total
Footnotes (1)
  • [F1]Represents the number of shares of Class A Common Stock underlying the restricted stock units ("RSUs") under Issuer's 2021 Equity Incentive Plan. One-third of the RSUs vest on August 20, 2023, rounded to the nearest whole share, and the remaining RSUs vest on August 20, 2024, subject to the Reporting Person's continuous service through each vesting date.

Issuer

Vera Therapeutics, Inc.

CIK 0001831828

Entity typeother

Related Parties

1
  • filerCIK 0001859386

Filing Metadata

Form type
4
Filed
Aug 22, 8:00 PM ET
Accepted
Aug 23, 4:11 PM ET
Size
8.2 KB